Travere Therapeutics, Inc. · NASDAQ:TVTX
BlackRock, Inc. reported a 9.40% stake in Travere Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 5, 2025
BlackRock, Inc. reported a 9.40% stake in Travere Therapeutics, Inc., 8,018,292 shares, as a passive investor on Dec 31, 2024. Filed Feb 5, 2025 (Schedule 13G/A).
- Stake
- 9.40%
- Shares
- 8,018,292
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 9.40% | 8,018,292 |
Source
Related
- Travere Therapeutics, Inc.
- BlackRock, Inc.
- Travere Therapeutics, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Apr 17, 2025
- Form 4 · Dube Eric M · Oct 19, 2026
- Form 4 · Heerma Peter · Sep 17, 2026
- Form 4 · Dube Eric M · Sep 17, 2026
- Form 4 · Rote William E. · Sep 17, 2026
- Form 4 · Inrig Jula · Sep 17, 2026